Objective: Morphologic diagnosis and grading of anal squamous intraepithelial lesions (ASILs) are challenging. In this study, we investigated interobserver variability and p16 utility in accurately grading anal SIL.

Materials And Methods: Six pathologists evaluated the degree of SIL on hematoxylin and eosin slides from 146 anal biopsies, followed by the review of both p16 and hematoxylin and eosin slides in cases where p16 was previously performed. κ was calculated in the following 4 ways: (A) 4-tiered diagnosis (negative for SIL [NSIL], anal intraepithelial neoplasia [AIN 1, AIN 2, AIN 3]); (B) 3-tiered diagnosis (NSIL and AIN 1 [pooled], AIN 2, AIN 3); (A) 3-tiered diagnosis (NSIL, low-grade SIL, high-grade SIL [HSIL]); and (D) 2-tiered diagnosis (no HSIL, HSIL).

Results: There is only moderate agreement with a 4-tiered diagnosis with or without p16 (κ = 0.48-0.57). There is substantial agreement when AIN 2 and AIN 3 are pooled as HSIL in cases with or without p16 review (κ = 0.71-0.78). There is almost perfect agreement with a 2-tiered diagnosis of negative for HSIL and HSIL both in cases where p16 was used and where p16 was not required, with the best agreement for a 2-tiered diagnosis with concurrent p16 review.

Conclusions: This study highlights the importance of a judicious use of p16 for diagnosis. When there is no need for p16 by the Lower Anogenital Squamous Terminology guidelines, interobserver agreement was substantial to almost perfect with a 2-tiered diagnosis. However, when its use is indicated but it is not performed or reviewed, the agreement is much lower even with a 2-tiered diagnosis. Rational use of p16 will ensure diagnostic accuracy and the best possible patient care.

Download full-text PDF

Source
http://dx.doi.org/10.1097/LGT.0000000000000500DOI Listing

Publication Analysis

Top Keywords

2-tiered diagnosis
20
p16
12
cases p16
12
ain ain
12
diagnosis
11
anal squamous
8
squamous intraepithelial
8
intraepithelial lesions
8
interobserver variability
8
grading anal
8

Similar Publications

Background: Since 2019, modified 2-tiered testing (MTTT) algorithms have been available for the diagnosis of Lyme disease. MTTTs replaced the standard algorithms that utilized enzyme immunoassays and immunoblots with sequential enzyme immunoassays that detect different antigens.

Methods: We compared the performance of serological assays from ZEUS Scientific Inc.

View Article and Find Full Text PDF

The skeletal health of laying hens improves when birds are given opportunities to perform load-bearing movements with elevated structures, such as perches. We investigated how early access to elevated structures varying in complexity and height would affect bone quality and subsequent keel bone fractures in a layer multitiered aviary. Female Dekalb White pullets were reared in floor pens furnished with floor perches (FL), single-tiered aviaries (ST), or 2-tiered aviaries (TT; n = 5 pens/treatment) through 16 wk of age.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the prevalence of ECG abnormalities in children diagnosed with Lyme arthritis to understand if there is an overlap with carditis, which commonly occurs in early Lyme disease.
  • Out of 233 pediatric patients with Lyme arthritis, only 90 had ECGs performed, and abnormalities were found in 5.6% of these cases, including instances of first-degree atrioventricular block and QTc prolongation.
  • The findings suggest that such ECG abnormalities are rare and do not indicate clinically significant heart issues, implying that routine ECG screening for asymptomatic kids with Lyme arthritis is unnecessary.
View Article and Find Full Text PDF

Background: Modified 2-tiered testing (MTTT) for Lyme disease utilizes automatable, high throughput immunoassays (AHTIs) in both tiers without involving western immunoblots, offering performance and practical advantages over standard 2-tiered testing (STTT; first-tier AHTI followed by immunoglobulin M (IgM) and immunoglobulin G (IgG) western immunoblots). For MTTT, Centers for Disease Control and Prevention recommends using AHTI test kits that have been cleared by Food and Drug Administration (FDA) specifically for this intended use. We evaluated performance of FDA-cleared MTTT commercial test kits from 3 manufacturers by comparing with STTT results.

View Article and Find Full Text PDF

Current therapies for multiple sclerosis (MS) often have limited efficacy and side effects, necessitating alternative approaches. Noninvasive brain stimulation (NIBS), such as transcranial direct current stimulation and transcranial magnetic stimulation (TMS), offers potential solutions. Among NIBS techniques, theta burst stimulation (TBS) is notable for its ability to modulate cortical activity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!